Abstract:The absorptive or renal origin of hypercalciuria can be discriminated using an acute oral calcium load test (ACLT). Of 86 patients with calcium oxalate kidney stones, 28 (23%) were found to be hypercalciuric (HCa) and 58 (67%) normocalciuric (NCa) on their customary free diet, containing 542 +/- 29 mg/day (mean +/- SE) of calcium. Since the apparently normal 24-hour calcium excretion of many calcium stone formers (CSF) may be due to a combination of high calcium absorption with moderately low calcium intake, all patients were investigated by ACLT. Of 28 HCa patients, 13 (46%) were classified as absorptive (AH) and 15 (54%) as renal hypercalciuria (RH). Of the 58 NCa patients, 38 (65%) presented features of intestinal hyperabsorption and were therefore designated as AH-like, and 20 (35%) as RH-like. To further elucidate the role of dietary calcium in these CSF, a chronic calcium load test (CCLT), consisting of 1 g/day of oral Ca for 7 days, was designed. A positive response to the CCLT was considered to occur when urinary calcium (uCa) was > or = 4 mg/ kg/24 h on the 7th day. Among NCa patients, 29% of AH-like subjects responded to the CCLT and 71% did not; 50% of RH-like subjects also responded and 50% did not. In HCa patients, 85% of AH and 67% of RH subjects maintained uCa > or = 4 mg/kg/24 h after the CCLT and 15% of AH and 23% of RH subjects did not. However, a significant additional increase in mean uCa was not observed among HCa patients. All patients were submitted to a second evaluation of fasting calciuria (Ca/Cr). A modification of this parameter was noticed in 89% of RH-like and 78% of RH patients. In conclusion, these data suggest the presence of subpopulations of patients sensitive or not to calcium intake, regardless of whether the acute response to a calcium overload test suggested AH or RH. The CCLT disclosed dietary hypercalciuria in 21/58 (36%) of previously NCa patients. In these NCa patients, the ACLT may be replaced by the CCLT. The distinction between AH and RH initially evidenced by the ACLT was not further confirmed. These data suggest that either fasting Ca/Cr is not adequate for subclassification of HCa or that AH and RH represent a different spectrum of the same disease, and that a primary resorptive component should also be considered.

Expression Profiles of Claudin Gene Family Members in Patients With Recurrent Calcium Oxalate Kidney Stones

CCL7 and olfactory transduction pathway activation play an important role in the formation of CaOx and CaP kidney stones

Activation of the Ca(2+)-sensing receptor increases renal claudin-14 expression and urinary Ca(2+) excretion

The Expression of the Claudin Family of Proteins in Colorectal Cancer

Revealing the molecular landscape of calcium oxalate renal calculi utilizing a tree shrew model: a transcriptomic analysis of the kidney

Expression of Claudins in Human Clear Cell Renal Cell Carcinoma.

Genetics of kidney stone disease-Polygenic meets monogenic

Dysregulation of Claudin Family Genes in Colorectal Cancer in a Chinese Population.

Correlation between clusterin expression and recurrence of calcium oxalate kidney stone

Claudins in Renal Physiology and Pathology

Analysis Of Altered Microrna Expression Profiles In Proximal Renal Tubular Cells In Response To Calcium Oxalate Monohydrate Crystal Adhesion: Implications For Kidney Stone Disease

Expression profiles of urine exosomal tRNA-derived small RNAs and their potential roles in calcium oxalate stone disease

Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects

Sensitivity to calcium intake in calcium stone forming patients

Two distinct phenotypes of calcium oxalate stone formers could imply different long-term risks for renal function

Expression of claudin-8 is induced by aldosterone in renal collecting duct principal cells

Association Between Calcitonin Receptor Gene Polymorphisms and Calcium Stone Urolithiasis: A Meta-Analysis

Oxalate-induced changes in renal epithelial cell function: role in stone disease

A Cause of Monogenic Kidney Stones and Nephrocalcinosis

Intestinal Oxalate Absorption, Enteric Hyperoxaluria, and Risk of Urinary Stone Formation in Patients with Crohn's Disease

Research on the relationship between SLC2A9 gene polymorphism in rs938552 and nephrolithiasis